ATHENA: Natural History of Disease Study in Alport Syndrome Patients
Condition: Alport Syndrome Patients With Measured GFR Between 30-75 ml/MinIntervention: Sponsor: Regulus Therapeutics Inc.Recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2014 Category: Research Source Type: clinical trials
ATHENA: Natural History of Disease Study in Alport Syndrome Patients
Condition: Alport Syndrome Patients With Measured GFR Between 30-75 ml/MinIntervention: Sponsor: Regulus Therapeutics Inc.Recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2014 Category: Research Source Type: clinical trials
ATHENA: Natural History of Disease Study in Alport Syndrome Patients
Condition: Alport Syndrome Patients With Measured GFR Between 30-75 ml/MinIntervention: Sponsor: Regulus Therapeutics Inc.Recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2014 Category: Research Source Type: clinical trials
ATHENA: Natural History of Disease Study in Alport Syndrome Patients
Condition: Alport Syndrome Patients With Measured GFR Between 30-75 ml/MinIntervention: Sponsor: Regulus Therapeutics Inc.Recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2014 Category: Research Source Type: clinical trials
ATHENA: Natural History of Disease Study in Alport Syndrome Patients
Condition: Alport Syndrome Patients With Measured GFR Between 30-75 ml/MinIntervention: Sponsor: Regulus Therapeutics Inc.Recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2014 Category: Research Source Type: clinical trials